Immucell (ICCC) Liabilities and Shareholders Equity (2010 - 2026)
Immucell (ICCC) recorded Liabilities and Shareholders Equity of $46.63 million in Q2 2026, up 9.6% from $42.53 million a year earlier.
Powered by 
Analysis
Immucell (ICCC) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Immucell reported Liabilities and Shareholders Equity of $42.53 million, down 5.7% from FY2024.
- Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $45.1 million in FY2024 (+3.0%), $43.81 million in FY2023 (-2.3%), $44.86 million in FY2022 (+0.9%) and $44.47 million in FY2021 (+10.2%).
- The Q2 2026 figure is the highest quarterly Liabilities and Shareholders Equity since Q1 2022.
- On a year-over-year basis, Liabilities and Shareholders Equity rose in five of the last seven quarters, with growth averaging 2.4%.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 17.9% in Q1 2022, against a decline of 7.7% in Q1 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn | 46.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.63 Mn |
| Dec 31, 2025 | 42.53 Mn |
| Sep 30, 2025 | 45.73 Mn |
| Jun 30, 2025 | 42.53 Mn |
| Mar 31, 2025 | 45.62 Mn |
| Dec 31, 2024 | 45.10 Mn |
| Sep 30, 2024 | 44.45 Mn |
| Jun 30, 2024 | 41.86 Mn |
| Mar 31, 2024 | 43.05 Mn |
| Dec 31, 2023 | 43.81 Mn |
| Sep 30, 2023 | 44.55 Mn |
| Jun 30, 2023 | 44.01 Mn |
| Mar 31, 2023 | 43.12 Mn |
| Dec 31, 2022 | 44.86 Mn |
| Sep 30, 2022 | 46.40 Mn |
| Jun 30, 2022 | 45.98 Mn |
| Mar 31, 2022 | 46.70 Mn |
| Dec 31, 2021 | 44.47 Mn |
| Sep 30, 2021 | 44.23 Mn |
| Jun 30, 2021 | 43.73 Mn |
API Access
Immucell Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();